BMRN - BioMarin CLO Davis sells stock worth $1.3M - filing
2023-12-15 12:11:32 ET
More on BioMarin Pharmaceutical
- BioMarin: Keeping Bullish View After Q3 Earnings
- BioMarin Pharmaceutical 2023 Q3 - Results - Earnings Call Presentation
- Biomarin Pharmaceutical Q3 2023 Earnings Call Transcript
- BioMarin Pharmaceutical officer disposes stake worth $1.31M under trading plan
- Wells Fargo starts BioMarin at overweight, cites activist involvement
For further details see:
BioMarin CLO Davis sells stock worth $1.3M - filing